Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mohammedyusuf Hajee (NPI 1316085566)

Field	Value
Entity Type	Individual
Organization	Mohammedyusuf Hajee
Address	780 Rte 37 W
City	Toms River
State	NJ
ZIP	08755
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	February 1, 2007

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider bills Medicare at scale with Total Medicare revenue: $2.6M and has no Medicaid billing on file, making their portfolio effectively single‑payer (Medicare) in scope. The absence of Medicaid activity suggests the provider’s patient mix and contracting are focused on the Medicare population rather than dual‑eligible or Medicaid-managed care panels.

Revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 71.2% of this provider's total Medicare revenue. Those top codes are J0178 ($1.2M, 45.8% of Medicare revenue), 92014 ($422.6K, 16.5%), and 67028 ($228.3K, 8.9%), indicating most dollars come from a small set of drug and procedure codes.

The code mix is characteristic of a retina specialty practice that combines high volumes of intravitreal drug therapy with procedure support: J0178 (aflibercept), J2777 (faricimab), J9035 (bevacizumab), J2778 (ranibizumab) and the intravitreal injection code 67028 appear throughout the top code list. This pattern shows the operation is centered on repeated anti-VEGF treatment visits and associated injection procedures rather than episodic general ophthalmology care.

High utilization of diagnostic and imaging services supports active disease management: 92134 (OCT retinal imaging) generated $148.8K and ranks #79 of 26868 providers nationally (100th percentile; extreme outlier), while angiography codes such as 92242 ($118.4K, rank #14 of 206, 94th percentile; notably above typical) and 92235 ($89.3K, rank #42 of 2192, 98th percentile; notably above typical) are also prominent. Combined with the very large volume of established comprehensive visits under 92014 (4.3K claims, $422.6K, rank #14 of 35415, 100th percentile; extreme outlier), this indicates a workflow emphasizing frequent monitoring and imaging alongside treatment.

Competitive standing is mixed by service line: the provider is an extreme national outlier for comprehensive established visits (92014) and for OCT (92134), signaling regional or niche dominance in patient follow-up and retinal imaging. By contrast J0178 (aflibercept) ranks #687 of 3204 (79th percentile; typical, unremarkable volume), so while drug revenue is large in dollar terms, the provider is not uniformly dominant among injectable drug prescribers at the national level.

Tenure is long enough to indicate an established practice: NPI enumerated 2007-02-01 (~19 years ago). Coupled with 4.3K claims for 92014, the evidence points to a sizable, stable established‑patient panel requiring ongoing retina care and surveillance.

The financial profile shows dependence on high-cost drug administration and supportive procedures: J0178 drives $1.2M of the Medicare revenue with an avg paid/claim of $691, and 67028 accounts for $228.3K. This drug+procedure revenue mix implies that changes in drug utilization patterns, payer reimbursement for injections, or access to specific therapies could materially affect overall Medicare revenue concentration.

Absence of Medicaid activity is notable for network and access considerations: because there is no Medicaid billing on file, the provider’s referral network, payer mix, and growth strategies are likely concentrated around Medicare beneficiaries and commercial referrals rather than Medicaid populations. For payer/provider analysts, this single‑payer skew should be considered when evaluating competitive positioning and potential gaps in coverage for lower‑income patients.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,700	$690	$1.2M
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	4,270	$100	$422.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,480	$90	$228.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	6,600	$30	$191.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,510	$30	$148.8K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	520	$230	$118.4K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	770	$120	$89.3K
J9035	Injection, bevacizumab, 10 mg	1,370	$60	$76.9K
J2778	Injection, ranibizumab, 0.1 mg	270	$170	$46.1K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	230	$130	$30.1K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Mohammedyusuf Hajee — 6 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	14	90	880	$690	$693.6K
J2777	38	60	8,820	$30	$319K
J2778	40	40	1,140	$180	$240.8K
67028	4	100	810	$100	$91.1K
92242	2	10	440	$230	$81.3K
92014	1	1,130	160	$100	$34.9K
92012	421	800	140	$70	$18.5K
92235	1	70	60	$120	$17.3K
J9035	3	60	80	$50	$14.2K
92287	2	20	90	$130	$14.2K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mohammedyusuf Hajee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Haris Amin	NJ	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Ravi Patel	NJ	Retina Specialist (Ophthalmology) Physician	$1.7M	$84.4K

Nearby Providers

Other providers in the same ZIP code as Mohammedyusuf Hajee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Medical Center Inc	NJ	General Acute Care Hospital	$0	$88.3M
Preferred Behavioral Health Of Nj	NJ	Community/Behavioral Health Agency	$0	$18.3M
Community Surgical Supply Of Toms River LLC	NJ	Oxygen Equipment & Supplies (DME)	$0	$17M
Spring Oak Of Toms River Alp LLC	NJ	Assisted Living Facility	$0	$10.1M
Magnolia Gardens South LP	NJ	Assisted Living Facility	$0	$8.1M
Jersey Innovative Services LLC	NJ	Community/Behavioral Health Agency	$0	$7.9M
The Residence At Lakeridge LLC	NJ	Assisted Living Facility	$0	$7.6M
Ocean County Eye Associates LLC	NJ	Ambulatory Surgical Clinic/Center	$3.4M	$0
David Dickerson	NJ	Orthopaedic Surgery Physician	$171.5K	$1.7M
Vipul Lakhani	NJ	Ophthalmology Physician	$1.1M	$0

Mohammedyusuf Hajee — Billing Profile & Reimbursement Data

Sign up for Mohammedyusuf Hajee — Billing Profile & Reimbursement Data policy alerts

Mohammedyusuf Hajee — Billing Profile & Reimbursement Data

Sign up for Mohammedyusuf Hajee — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References